E7080 (Lenvatinib)

E7080, also known as Lenvatinib, is a targeted cancer medication that blocks certain proteins (referred to as kinases) involved in tumor growth and blood vessel formation. By inhibiting these proteins, Lenvatinib reduces the supply of nutrients to the tumor, helping to slow or stop its growth. It is used to treat various cancers, including thyroid, kidney, and liver cancers. Patients usually take it orally as a pill, and it may cause side effects like fatigue, high blood pressure, or diarrhea. Overall, it is a focused therapy aimed at disrupting specific pathways vital for cancer progression.